-
Rethinking Access to Disability Benefits
Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.
by Jen Tota McGivney
-
April 30: The Week in Cancer News
President Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.
by Bradley Jones
-
Making Connections at the AACR Annual Meeting 2021
Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.
by Bradley Jones
-
Building COVID-19 Vaccine Confidence
Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.
by Kevin McLaughlin
-
Chemobrain: It’s Not Your Imagination
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Forward Look
Making Cancer Clinical Trials More InclusiveDespite efforts by policymakers, a gender gap persists in clinical trial participation.
by Lindsey Konkel
-
Policy Matters
Research Advocacy During COVID-19Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.
by Brandon Leonard, MA, and Marc Johnson, MPP
-
Q&A
Up for DebateHematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.
by Marci A. Landsmann
-
Get Involved
Cakes for CancerInspired by a family friend, Chase Sloan has published a recipe book with proceeds going toward cancer research.
by Erin O'Donnell
-
Survivor Profile
A Return to CarnivalWith a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.
by Lindsey Konkel
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff